2026 Q2 Portfolio Activity
In 2026 Q2, Sofinnova Investments, Inc. maintained a portfolio of 87 distinct positions. The most significant new addition was Gilead Sciences Inc, now representing 2.24% of the total fund value. They heavily accumulated shares in Genmab A/S, increasing the position by 437.7%. Conversely, Sofinnova Investments, Inc. completely exited their position in iShares TR.
Position History
hover any row below to update
Loading…
Total Positions
87
Quarter
2026 Q2
Top Holding
NTRA (21.8%)
Top 10 Concentration
57.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 87
Sofinnova Investments, Inc. Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NTRA
Natera Inc
|
Healthcare | 21.76% | 11.78% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
1,550,280 | $420,823,506 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
Vera Therapeuti...
|
Healthcare | 6.20% | 4.27% |
#2
4
Prev: #6
|
5.0 |
—
|
no change | no change |
P
S
|
2,793,987 | $119,889,982 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMAB
Genmab A/S
|
Healthcare | 5.74% | 0.77% |
#3
35
Prev: #38
|
6.3 |
—
|
3,292,954 | 437.7% |
P
S
|
4,045,215 | $111,122,056 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JAZZ
Jazz Pharmaceut...
|
Healthcare | 4.55% | 4.30% |
#4
1
Prev: #5
|
2.3 |
—
|
-232,986 | -38.9% |
P
S
|
365,341 | $88,036,221 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RAPP
Rapport Therape...
|
Healthcare | 4.10% | 2.26% |
#5
8
Prev: #13
|
3.1 |
—
|
no change | no change |
P
S
|
1,904,408 | $79,356,681 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Seaport Therape...
|
|
Unknown | 4.00% | — |
#6
Prev: #—
|
5.1 |
—
|
3,564,871 | — |
NEW
|
3,564,871 | $77,428,998 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AVBP
Arrivent BioPha...
|
Healthcare | 3.05% | 1.49% |
#7
16
Prev: #23
|
2.2 |
—
|
no change | no change |
P
S
|
1,696,752 | $58,945,164 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
Ultragenyx Phar...
|
Healthcare | 2.96% | 2.50% |
#8
4
Prev: #12
|
1.2 |
—
|
-1,428,383 | -45.4% |
P
S
|
1,717,505 | $57,347,492 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
BioAge Labs Inc
|
Healthcare | 2.91% | 1.52% |
#9
12
Prev: #21
|
2.2 |
—
|
no change | no change |
P
S
|
2,293,788 | $56,220,744 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMY
Bristol-Myers S...
|
Healthcare | 2.61% | 4.58% |
#10
6
Prev: #4
|
1.0 |
—
|
-1,111,751 | -55.9% |
P
S
|
876,970 | $50,531,011 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SUPN
Supernus Pharma...
|
Healthcare | 2.49% | 1.87% |
#11
5
Prev: #16
|
3.0 |
—
|
82,019 | 8.6% |
P
S
|
1,036,328 | $48,199,615 | 2020 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
Rhythm Pharmace...
|
Healthcare | 2.34% | 1.49% |
#12
10
Prev: #22
|
1.4 |
—
|
-42,069 | -9.3% |
P
S
|
408,027 | $45,303,238 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GILD
Gilead Sciences...
|
Healthcare | 2.24% | — |
#13
Prev: #—
|
4.4 |
—
|
343,100 | — |
NEW
|
343,100 | $43,347,254 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
United Therapeu...
|
Healthcare | 2.14% | 3.61% |
#14
7
Prev: #7
|
0.9 |
—
|
-83,581 | -52.2% |
P
S
|
76,489 | $41,444,035 | 2019 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
Cogent Bioscien...
|
Healthcare | 2.07% | 3.09% |
#15
5
Prev: #10
|
0.8 |
—
|
-1,078,403 | -51.0% |
P
S
|
1,035,148 | $40,060,228 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXSM
Axsome Therapeu...
|
Healthcare | 2.03% | 1.37% |
#16
11
Prev: #27
|
0.8 |
—
|
-52,318 | -24.6% |
P
S
|
160,429 | $39,268,206 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMTX
Immatics N.V
|
Healthcare | 1.92% | 1.36% |
#17
11
Prev: #28
|
1.3 |
—
|
38,892 | 1.1% |
P
S
|
3,669,346 | $37,170,475 | 2020 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
Dyne Therapeuti...
|
Healthcare | 1.90% | 1.13% |
#18
14
Prev: #32
|
1.3 |
—
|
24,487 | 1.5% |
P
S
|
1,658,384 | $36,832,709 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMNM
Immunome Inc
|
Healthcare | 1.88% | 1.41% |
#19
6
Prev: #25
|
1.3 |
—
|
18,412 | 1.1% |
P
S
|
1,720,316 | $36,453,496 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IDYA
IDEAYA Bioscien...
|
Healthcare | 1.78% | 1.43% |
#20
4
Prev: #24
|
1.2 |
—
|
-206,667 | -18.3% |
P
S
|
925,119 | $34,479,185 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANAB
Anaptysbio Inc
|
Healthcare | 1.72% | 0.52% |
#21
22
Prev: #43
|
3.7 |
—
|
245,283 | 98.8% |
P
S
|
493,536 | $33,313,680 | 2018 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
Nektar Therapeu...
|
Healthcare | 1.70% | 1.39% |
#22
4
Prev: #26
|
1.2 |
—
|
-37,783 | -7.4% |
P
S
|
471,763 | $32,933,775 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PHVS
Pharvaris N V
|
Healthcare | 1.58% | 0.88% |
#23
12
Prev: #35
|
2.6 |
—
|
62,971 | 7.7% |
P
S
|
881,299 | $30,475,319 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RCUS
Arcus Bioscienc...
|
Healthcare | 1.51% | 0.76% |
#24
15
Prev: #39
|
1.1 |
—
|
22,604 | 2.4% |
P
S
|
945,690 | $29,155,623 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INBX
Inhibrx Bioscie...
|
Healthcare | 1.48% | 1.04% |
#25
8
Prev: #33
|
0.6 |
—
|
-102,926 | -25.3% |
P
S
|
303,103 | $28,719,009 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BMRN
BioMarin Pharma...
|
Healthcare | 1.06% | 1.68% |
#26
8
Prev: #18
|
0.4 |
—
|
-423,414 | -54.1% |
P
S
|
358,568 | $20,517,261 | 2018 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
Veradermics Inc
|
|
Unknown | 0.95% | 0.18% |
#27
30
Prev: #57
|
3.4 |
—
|
75,678 | 103.2% |
P
S
|
148,993 | $18,317,199 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ALC
Alcon AG
|
Healthcare | 0.89% | 2.09% |
#28
13
Prev: #15
|
0.4 |
—
|
-474,148 | -65.0% |
P
S
|
255,824 | $17,165,790 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
Insmed Inc
|
Healthcare | 0.87% | 2.15% |
#29
15
Prev: #14
|
0.3 |
—
|
-187,677 | -54.2% |
P
S
|
158,398 | $16,888,395 | 2019 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
CALL
Ultragenyx Phar...
|
CALL Option | 0.86% | 0.28% |
#30
22
Prev: #52
|
2.8 |
—
|
150,000 | 42.9% |
P
S
|
500,000 | $16,695,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
CALL
Intuitive Surgi...
|
CALL Option | 0.82% | — |
#31
Prev: #—
|
3.8 |
—
|
40,000 | — |
NEW
|
40,000 | $15,907,200 | 2022 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GMED
CALL
Globus Med Inc
|
CALL Option | 0.82% | — |
#32
Prev: #—
|
3.8 |
—
|
200,000 | — |
NEW
|
200,000 | $15,802,000 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
Edgewise Therap...
|
Healthcare | 0.80% | 0.46% |
#33
12
Prev: #45
|
0.8 |
—
|
-5,575 | -1.4% |
P
S
|
380,923 | $15,476,901 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EXEL
PUT
Exelixis Inc
|
PUT Option | 0.72% | 0.41% |
#34
13
Prev: #47
|
0.8 |
—
|
2,700 | 1.1% |
P
S
|
254,200 | $13,831,022 | 2018 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NRIX
Nurix Therapeut...
|
Healthcare | 0.66% | — |
#35
Prev: #—
|
3.8 |
—
|
524,098 | — |
NEW
|
524,098 | $12,714,617 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DSGN
Design Therapeu...
|
Healthcare | 0.65% | — |
#36
Prev: #—
|
3.8 |
—
|
865,135 | — |
NEW
|
865,135 | $12,518,503 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
Definium Therap...
|
Healthcare | 0.62% | 0.25% |
#37
17
Prev: #54
|
0.2 |
—
|
-88,263 | -25.6% |
P
S
|
255,903 | $12,037,677 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
First Tracks Bi...
|
|
Unknown | 0.59% | — |
#38
Prev: #—
|
3.7 |
—
|
565,199 | — |
NEW
|
565,199 | $11,371,804 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ABT
Abbott Laborato...
|
Healthcare | 0.58% | — |
#39
Prev: #—
|
3.7 |
—
|
122,998 | — |
NEW
|
122,998 | $11,160,839 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
Disc Medicine I...
|
Healthcare | 0.55% | 0.19% |
#40
16
Prev: #56
|
3.2 |
—
|
67,919 | 86.7% |
P
S
|
146,239 | $10,695,920 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TENX
Tenax Therapeut...
|
Healthcare | 0.38% | 0.06% |
#41
25
Prev: #66
|
3.2 |
—
|
395,639 | 379.0% |
P
S
|
500,039 | $7,275,567 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SION
Sionna Therapeu...
|
Healthcare | 0.33% | — |
#42
Prev: #—
|
3.6 |
—
|
144,432 | — |
NEW
|
144,432 | $6,353,564 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABSI
Absci Corporati...
|
Healthcare | 0.20% | — |
#43
Prev: #—
|
3.6 |
—
|
337,400 | — |
NEW
|
337,400 | $3,910,466 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MIRM
Mirum Pharmaceu...
|
Healthcare | 0.17% | 0.10% |
#44
17
Prev: #61
|
1.1 |
—
|
no change | no change |
P
S
|
27,591 | $3,230,078 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
Jade Bioscience...
|
Healthcare | 0.12% | 0.06% |
#45
22
Prev: #67
|
1.0 |
—
|
no change | no change |
P
S
|
107,391 | $2,386,228 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
Savara Inc
|
Healthcare | 0.12% | 0.08% |
#46
17
Prev: #63
|
1.0 |
—
|
no change | no change |
P
S
|
364,763 | $2,246,940 | 2018 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
Praxis Precisio...
|
Healthcare | 0.11% | 0.78% |
#47
10
Prev: #37
|
0.0 |
—
|
-57,240 | -89.9% |
P
S
|
6,440 | $2,156,048 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
Septerna Inc
|
Healthcare | 0.08% | 0.04% |
#48
21
Prev: #69
|
1.0 |
—
|
no change | no change |
P
S
|
47,506 | $1,590,976 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OKUR
Onkure Therapeu...
|
Healthcare | 0.08% | 0.02% |
#49
21
Prev: #70
|
3.0 |
—
|
179,992 | 127.0% |
P
S
|
321,692 | $1,466,916 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SGMT
Sagimet Bioscie...
|
Healthcare | 0.07% | — |
#50
Prev: #—
|
3.5 |
—
|
166,667 | — |
NEW
|
166,667 | $1,288,336 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 87 holdings